Literature DB >> 8021960

Simultaneous administration of CPT-11 and fluorouracil: alteration of the pharmacokinetics of CPT-11 and SN-38 in patients with advanced colorectal cancer.

Y Sasaki, A Ohtsu, Y Shimada, K Ono, N Saijo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8021960     DOI： 10.1093/jnci/86.14.1096

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

Review 1.  Clinical pharmacokinetics of irinotecan.

Authors:  G G Chabot
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 2.  Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.

Authors:  L R Wiseman; A Markham
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

3.  A risk-benefit assessment of irinotecan in solid tumours.

Authors:  L L Siu; E K Rowinsky
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

4.  Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.

Authors:  Masayoshi Yasui; Masataka Ikeda; Mitsugu Sekimoto; Hirofumi Yamamoto; Ichiro Takemasa; Takafumi Ueda; Junzo Shimizu; Mutsumi Fukunaga; Osamu Suzuki; Takehiro Inoue; Morito Monden
Journal:  World J Surg Oncol       Date:  2006-11-22       Impact factor: 2.754

Review 5.  Treatment of colorectal cancer. Current guidelines and future prospects for drug therapy.

Authors:  R Labianca; M A Pessi; G Zamparelli
Journal:  Drugs       Date:  1997-04       Impact factor: 11.431

6.  Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer.

Authors:  M Inokuchi; T Yamashita; H Yamada; K Kojima; W Ichikawa; Z Nihei; T Kawano; K Sugihara
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

Review 7.  Highlights for ESMO 40: celebration review for lifetime achievement awards.

Authors:  Nagahiro Saijo
Journal:  ESMO Open       Date:  2016-02-17

8.  Assessment of the Safety and Efficacy of Edoxaban for the Treatment of Venous Thromboembolism Secondary to Active Malignancy.

Authors:  Nobuhiro Hara; Takamichi Miyamoto; Takamasa Iwai; Junji Yamaguchi; Sadahiro Hijikata; Keita Watanabe; Yuichiro Sagawa; Ryo Masuda; Ryoichi Miyazaki; Naoyuki Miwa; Masahiro Sekigawa; Tetsuo Yamaguchi; Yasutoshi Nagata; Toshihiro Nozato; Toru Obayashi
Journal:  Ann Vasc Dis       Date:  2017-12-25

9.  Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer.

Authors:  T Yoshioka; S Kato; M Gamoh; N Chiba; T Suzuki; N Sakayori; S Kato; H Shibata; H Shimodaira; K Otsuka; Y Kakudo; S Takahashi; C Ishioka
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.